The ecotropic murine leukemia virus (E-MuLV) receptor expressed on Mus dunni tail fibroblast (MDTF) cells is a receptor for all E-MuLVs with the notable exception of Moloney murine leukemia virus (Mo-MuLV). Substitution of isoleucine for valine at position 214 in the third extracellular region (the putative E-MuLV binding site) of the MDTF receptor molecule allows this molecule to function as a Mo-MuLV receptor (M. V. Eiden, K. Farrell, J. Warsowe, L. A. Mahan, and C. A. Wilson, J. Virol. 67:4056-4061, 1993). We have now determined that treating MDTF cells with tunicamycin, an inhibitor of N-linked glycosylation, also renders them susceptible to Mo-MuLV infection. Two potential N-linked glycosylation sites are present in the third extracellular regions of both the NIH 3T3 and MDTF ecotropic receptors. The glycosylation site at position 229 of the MDTF receptor cDNA was eliminated by substituting a threonine codon for the asparagine codon. Mo-MuLV-resistant human HOS cells, expressing this form of the receptor, are susceptible to Mo-MuLV infection. Thus, our studies suggest that without a glycan moiety at position 229, the valine residue at 214 is no longer restrictive for Mo-MuLV infection. BHK-21 and CHO Ki hamster cells also express glycosylationinactivated forms of the ecotropic receptor. Sequence analysis of these receptors together with our analysis of MDTF receptor function suggests that a single asparagine-linked glycosylation site is responsible for glycosylation inactivation of these receptors.
NIH 3T3 cells express a cell surface protein which functions as a receptor for all members of the ecotropic class of murine leukemia viruses (E-MuLVs). The cDNA for this receptor has been cloned, sequenced, and proposed to encode a glycoprotein containing 14 transmembrane domains (2) . The third extracellular region has been shown to be involved in virus binding and entry (1, 4, 16 ). This domain contains two potential N-linked glycosylation sites. More recently, this receptor has been identified as the widely expressed transporter for basic amino acids (5, 13) . The transporter protein is present on the cells of many species, but only the form of the transporter expressed on murine and rat cells can function as the receptor for ecotropic viruses.
Although all ecotropic viruses can use this receptor to enter target cells, some cells that are susceptible to infection by one ecotropic virus remain relatively resistant to infection by another. For example, the Mus dunni tail fibroblast (MDTF) cells initially described by Lander and Chattopadhyay are efficiently infected by all ecotropic viruses with the notable exception of Moloney murine leukemia virus (Mo-MuLV) (6) . We have now confirmed this observation and extended it to Mo-MuLV-based retroviral vectors (4) . MDTF cells can be efficiently infected by the ecotropic Friend murine leukemia virus (F-MuLV) as well as vectors that contain a Mo-MuLVbased genome and core and an F-MuLV envelope. In contrast to NIH 3T3 cells, no evidence of Mo-MuLV infection or spread can be detected in MDTF cells transfected with MoMuLV molecular clones. However, replication-competent MoMuLV can infect MDTF cells at a high multiplicity of infection, in contrast to human cells, in which resistance is absolute.
MDTF cells that express the NIH 3T3-derived ecotropic receptor after transfection of its cDNA are susceptible to Mo-MuLV-based vectors and replication-competent MoMuLV infection. These results suggest that differences in the ecotropic receptor expressed in NIH 3T3 cells and MDTF cells account for their disparate E-MuLV receptor functions (4) . We have cloned, sequenced, and functionally characterized the ecotropic receptor cDNA from MDTF cells and compared it with the ecotropic receptor expressed in NIH 3T3 cells. The MDTF ecotropic receptor cDNA is similar to the nonfunctional human ecotropic receptor homolog in that it contains a valine codon at position 214 in the third extracellular loop, whereas the functional NIH 3T3 receptor contains an isoleucine codon at this position (2, 4, 15 Calif.) per ml in a 12-well tissue culture dish as previously described (14) . Approximately 18 h later, cells were rinsed three times with fresh medium without tunicamycin and infected with 2 ml of filtered virus suspension. The next day, cells were trypsinized, seeded at a 1:10 dilution in a 10-cm-diameter tissue culture dish, and selected with G418 (150 ,ug/ml for HOS cells and 400 ,Lg/ml for MDTF cells).
Mutagenesis of the MDTF ecotropic receptor cDNA. The ecotropic receptor cDNA encoding a mutant form of the receptor lacking the potential N-linked glycosylation site was made by using a recombinant PCR protocol (7) . Four oligonucleotide primers corresponding to specific regions of the NIH 3T3 ecotropic receptor cDNA were designed (2 M7 (antisense) correspond to bases 851 to 886 and encode a single base change at base 880 resulting in the substitution of a threonine codon for the asparagine codon at this position, thus removing the glycosylation site. In the first round of PCR, two fragments of DNA were generated, using pLNS-mRec DNA as a template: one fragment extending from the J12 primer to the M7 primer, and the other fragment extending from the sense M6 primer to the J10 primer. These reactions were done on an automated thermal minicycler (MJ Research, Watertown, Mass.) (5 cycles of 1 min at 94°C, 2 min at 45°C, and 2 min at 72°C; 20 cycles of 1 min at 94°C, 2 min at 55°C, and 2 min at 72°C). The PCR products were purified by using Magic PCR Prep columns (Promega, Madison, Wis.) and then annealed at 70°C. The second round of PCR was performed on the annealed product, using the J12 and J10 primers (15 cycles of 1 min at 94°C, 2 min at 55°C, and 2 min at 72°C). This product was ligated into the TA pCRII cloning vector (Invitrogen, San Diego, Calif.) and sequenced by direct dideoxy sequencing (11) to ensure that the mutation was incorporated and that no unscheduled PCR-induced mutations were present. To construct the pLNS-mut229 retroviral expression plasmid, the HpaI-SphI fragment of this ecotropic receptor mutant (nucleotides 735 to 1792) was used to replace the corresponding fragment of pLNS-dRec.
Retroviral vector infection. CRE BAG and CRIP BAG cell lines were used as the sources of the Mo-MuLV and amphotropic murine leukemia virus (A-MuLV) vectors, respectively, used in these studies. The Escherichia coli lacZ 0-galactosidase and TnS neo genes are present in the BAG genome, and therefore infected cells can be identified by counting neomycin-resistant cell clones or by counting blue foci. The FrBAG vector was produced from GP9122 BAG cells transfected with an F-MuLV envelope expression plasmid as described previously (4). The retroviral vectors pLNS-mRec, pLNS-dRec, and pLNS-Mut 229, packaged in PG13 cells, were used to express the MDTF and NIH 3T3 ecotropic receptor cDNAs in BHK-21 and CHO Kl cells (4, 9, 14) . Human HOS cells expressing various ecotropic receptors were established following infection with a PA317-packaged pLNS-mRec, pLNSdRec, or pLNS-Mut229 genome.
Sequencing of hamster ecotropic receptor cDNAs. An internal segment of the BHK-21 and CHO Kl ecotropic receptor cDNA containing the third extracellular region was isolated by previously described methods (4). Briefly, polyadenylated RNA was isolated from each cell line and was used as template for a reverse transcription reaction primed by random hexadeoxyribonucleotides to make cDNA. Nested oligonucleotide primers were used to amplify the region between amino acid residues 276 and 384. The PCR products were ligated into the TA pCRII vector and sequenced.
RESULTS
The failure of the MDTF ecotropic receptor to function as a Mo-MuLV receptor is glycosylation dependent. CHO Kl and BHK-21 cells are resistant to infection by Mo-MuLV and Mo-MuLV-based retroviral vectors but can be made sensitive to Mo-MuLV infection after tunicamycin treatment (14) . We sought to determine whether MDTF cells are resistant to Mo-MuLV infection as a consequence of a similar glycosylation-dependent process. MDTF cells pretreated with tunicamycin were exposed to Mo-MuLV-based recombinant vectors containing the gene encoding neomycin phosphotransferase. Untreated MDTF and human HOS cells and tunicamycinpretreated HOS cells remained resistant, whereas MDTF cells pretreated with tunicamycin were efficiently infected by MoMuLV-based vectors (Fig. 1) . We have previously determined that transfection and expression of the NIH 3T3-derived ecotropic receptor cDNA in MDTF cells results in the acquisition of Mo-MuLV susceptibility (4) . These data together with the experimental results presented in Fig. 1 suggest that the ecotropic receptor expressed in MDTF cells is inherently different from the NIH 3T3 form of the ecotropic receptor and that the MDTF form of the receptor is inactivated by a glycosylation-dependent process. Two potential sites for N-linked glycosylation are present in the third extracellular domain of both the NIH 3T3 and MDTF receptor molecules, at positions 223 and 229 (Fig. 2) . Sitespecific mutagenesis was used to selectively eliminate the site at position 229 in the MDTF receptor cDNA, where a threonine codon was substituted for the asparagine codon. A retroviral vector expressing this mutant cDNA, pLNS-Mut 229, was introduced into HOS, CHO Kl, and BHK-21 cells, which (Table 3) . Expression of the NIH 3T3 ecotropic receptor cDNA in CHO Ki cells resulted in acquired susceptibility to both Mo-MuLV and F-MuLV infection (Table 1) .
In contrast, BHK-21 cells expressing the MDTF ecotropic receptor remain resistant to both Mo-MuLV and F-MuLV (Table 3) . However, when BHK-21 cells express the MDTF receptor containing the N-T substitution at position 229, they become susceptible to infection by both F-MuLV and MoMuLV (Table 1) . Therefore, the position 229 mutation removes both the selective block to F-MuLV function exhibited by the MDTF receptor in some cells and the total block to MDTF ecotropic receptor function exhibited by BHK-21 cells.
Sequence comparison of the third extracellular region of hamster, human, and murine ecotropic receptor cDNAs. To determine the molecular basis for the observed differences in BHK-21, CHO Kl, MDTF, human HUT 78, and NIH 3T3 cells regarding susceptibility to E-MuLV infection, we compared the deduced amino acid sequences of the third extracellular regions of these five receptor cDNAs. As shown in Fig.  3A , the NIH 3T3 form of the ecotropic receptor contains 31 amino acid residues (2). The MDTF form contains 32 residues (4), the BHK 21 and CHO Kl forms contain 38 residues, and the human form of the ecotropic receptor contains 39 residues in the third extracellular loop (15) . Both CHO Kl and the human receptor homologs contain three additional residues on either side of the first N-linked glycosylation site. The BHK-21 receptor homolog has a similar insertion of six amino acid residues but lacks the first glycosylation site present at position 223 in the other four forms of the receptor (Fig. 3A) . A proline residue is present in place of the requisite serine/threonine residue which constitutes the terminal amino acid residue in the Asn-X-Ser/Thr consensus sequence for N-linked glycosylation.
The BHK-21 and CHO Ki receptors are similar to the NIH 3T3 receptor and differ from both the MDTF and human forms of the receptor in that they contain an isoleucine rather than a valine residue at position 214 (Fig. 3A) . Finally, both the CHO Ki and BHK-21 receptors lack the additional amino acid residue inserted in the carboxy half of this domain that is present in both the MDTF and human forms of the receptor (positions 236 for MDTF and 242 for human). The MDTF form of the receptor has an additional glycine residue at position 236 (Fig. 3A) . All forms of the receptor contain four identical amino acid residues at both of the proposed end regions of this extracellular loop and at least one N-linked glycosylation site. The majority of differences are localized to three positions: position 214, the positions flanking the first of the two N-linked glycosylation sites, and finally at the position downstream of the second N-linked glycosylation site (approximately six amino acids from the C-terminal end of this domain). mia virus and F-MuLV but not Mo-MuLV. Hamster cells such as CHO Kl and BHK-21 express an ecotropic receptor subtype that is not functional in its native form for any of the E-MuLVs but can be rendered functional by the removal of N-linked carbohydrates (Fig. 3B) . (Table 1) . They differ from human cells in that resistance to E-MuLV is glycosylation mediated (14) . It (Table 3) . These collective findings suggest that both N-linked glycosylation patterns potentiated by different ecotropic receptor cDNAs and cellspecific N-linked glycosylation patterns affect the ability of various E-MuLVs to use these ecotropic receptors. Similar cell-specific posttranslational receptor modifications may account for the discrepancies between the previous reports regarding mutational inactivation of the ecotropic receptor by substitution of amino acid residues from the human receptor Comparing both the functions and the nucleotide sequences of the BHK-21, CHO Kl, NIH 3T3, MDTF, and human ecotropic receptor cDNAs has allowed us to identify three discontinuous epitopes or regions of the ecotropic receptor that facilitate, either directly or indirectly, E-MuLV entry. The two regions that appear directly involved in Mo-MuLV entry lie on opposing ends of this extracellular loop (position 214 and the residues at positions 235 to 237; Fig. 3 ). Glycosylation appears to block access of the viral particle to this critical region of the receptor, thereby restricting use of the hamster receptor by E-MuLVs and use of the MDTF receptor by Mo-MuLV.
